Use of the "clot-busting" drug tissue plasminogen activator (tPA) to treat patients with strokes caused by a blockage of blood flow nearly doubled between 2003 and 2011. A research team reports ...

Tissue plasminogen activator (tPA) is a medication that doctors administer following a stroke caused by a blood clot. It breaks up the blood clot to allow blood flow to return to the brain.

A phase 2 study has suggested that the glycoprotein (gp) IIb/IIIa blocker eptifibatide can be safely combined with a reduced dose of tPA in the treatment of acute ischemic stroke, and there was a ...

New research suggests that black stroke patients are 5 times less likely than white ones to receive tissue plasminogen activator (tPA) for ischemic stroke, a particularly provocative finding for a ...

THURSDAY, Oct. 17, 2024 (HealthDay News) -- For patients with acute ischemic stroke (AIS), tenecteplase (TNK) has improved functional outcome and reduced disability and similar safety to alteplase ...

About 87 percent of all strokes are ischemic, meaning they’re caused by a blood clot in the brain. For more than 20 years, the standard of care has been a drug called TPA. But now, some doctors ...

For patients receiving tissue plasminogen activator (tPA) after ischemic stroke, warfarin has no effect on the risk of symptomatic intracranial hemorrhage (sICH).

An ischemic stroke is a medical emergency caused by a blockage in a blood vessel that supplies blood to a region of the brain. Symptoms may include facial drooping, limb weakness on one side, and ...

Ischemic strokes, he explains, may be treated with clot-busting medications like tPA, or, in more severe cases, with specialized devices introduced through a catheter.

Adult patients with sickle cell disease who experience a stroke caused by a clot (i.e., ischemic strokes) can be treated safely with tissue plasminogen activator if they qualify, report investigators.

Use of tPA for ischemic stroke nearly doubled from 2003 to 2011 Date: August 21, 2013 Source: Massachusetts General Hospital Summary: Use of the "clot-busting" drug tissue plasminogen activator ...

The use of intravenous tissue plasminogen activator (IV tPA) in acute ischemic stroke (AIS) patients nearly doubled from 2003-2011.